dipalmitoleoylphosphatidylethanolamine and Lung-Neoplasms

dipalmitoleoylphosphatidylethanolamine has been researched along with Lung-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for dipalmitoleoylphosphatidylethanolamine and Lung-Neoplasms

ArticleYear
Dipalmitoleoyl-phosphatidylethanolamine induces apoptosis of NCI-H28 malignant mesothelioma cells.
    Anticancer research, 2014, Volume: 34, Issue:4

    The phospholipid phosphatidylethanolamine regulates a wide range of cellular processes. The present study investigated the antitumor effect of 1,2-dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (DPPE) on malignant pleural mesothelioma cells.. Activities of protein phosphatases (PPs) such as PP1, PP2A, and protein tyrosine phosphatase 1B (PTP1B) were assayed under cell-free conditions. 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, and western blotting were carried out on the human Met5A non-malignant mesothelial cell line and NCI-H28 malignant mesothelioma cell line.. DPPE significantly enhanced PP2A and PTP1B activities. DPPE tended to attenuate activity of extracellular signal-regulated kinase-1 (ERK1)/ERK2, with the greater efficacy for NCI-H28 cells than that for Met5A cells. DPPE reduced NCI-H28 cell viability in a concentration (1-100 μM)-dependent manner, while it had no effect on Met5A cell viability. DPPE markedly increased TUNEL-positive cells in the NCI-H28 cell line, but otherwise induced few TUNEL-positive cells in the Met5A cell line.. The results of the present study clearly demonstrate that DPPE induces apoptosis of NCI-H28 malignant pleural mesothelioma cells. DPPE-induced enhancement of PP2A and PTP1B activities might at least in part contribute to the apoptotic effect of DPPE.

    Topics: Antineoplastic Agents; Apoptosis; Carboxylic Ester Hydrolases; Cell Line, Tumor; Cell Survival; Enzyme Activation; Ethanolamines; Fatty Acids, Unsaturated; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mesothelioma; Mesothelioma, Malignant; Pleural Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 1

2014